← Back to headlines
Kazia Therapeutics Launches $40 Million Equity Offering
The biopharmaceutical company successfully prices a new public stock offering to fund ongoing clinical development programs and operational expansion.
28 Aug, 11:36 — 28 Aug, 11:36
Sources
Showing 1 of 1 sources
